ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,079, issued on June 17, was assigned to Arizona Board of Regents on behalf of Arizona State University (Scottsdale, Ariz.).
"Oncolytic virus platform to treat cancers with myxoma virus" was invented by Douglas Grant McFadden (Tempe, Ariz.), Mohammed Masmudur Rahman (Chandler, Ariz.), Nancy Villa (Tempe, Ariz.), Lino Torres-Dominguez (Tempe, Ariz.), Lina Franco Achury (Tempe, Ariz.) and Leslie Lynne Sharp (Rancho Santa Fe, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, in certain embodiments, are recombinant myxoma viruses (MYXVs) and nucleic acid constructs encoding the recombinant MYXVs. In some embodiments, the MYXVs are e...